Compugen Ltd.
NASDAQ:CGENBiotechnology
Healthcare
$1.96 +0.50%
+$0.01 today
- Market cap
- $185.66M
- Beta
- 2.74
- P/E (TTM)
- 5.4
- EPS (TTM)
- $0.37
52W Low $1.30High $3.24
Volume 0.15M
Average 0.48M
Balance Sheet
Inspect the capital base behind the business.
Assets
$156.87M
FY 2025 · Annual
+36.4% YoYLiabilities
$54.14M
FY 2025 · Annual
-9.9% YoYEquity
$102.73M
FY 2025 · Annual
+87.1% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7.8M | 11.06M | 13.89M | 18.23M | 90.6M |
| Short-term Investments | 109.25M | 72.29M | 36.8M | 85.03M | 55.04M |
| Net Receivables | 188K | 317K | 61.32M | 269K | 294K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 713K | 362K | 365K | 0 | 0 |
| Total Current Assets | 123.22M | 86.13M | 114.58M | 106M | 148.02M |
| Property, Plant & Equipment (Net) | 3.91M | 3.36M | 2.55M | 3.7M | 3.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 410K |
| Tax Assets | 0 | 0 | 0 | 0 | 303K |
| Other Non-current Assets | 5.04M | 4.69M | 4.21M | 5.3M | 4.94M |
| Total Non-current Assets | 8.94M | 8.05M | 6.76M | 9M | 8.85M |
| Total Assets | 132.16M | 94.18M | 121.33M | 115M | 156.87M |
| Account Payables | 4.62M | 1.77M | 3.5M | 1.84M | 2.35M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 11.15M | 9.63M | 10.97M |
| Other Current Liabilities | 6.93M | 3.14M | 3.13M | 3.07M | 3.05M |
| Total Current Liabilities | 17.1M | 11.92M | 26.27M | 20.16M | 22.57M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 303K |
| Deferred Revenue (Non-current) | 0 | 0 | 25.39M | 34.05M | 24.94M |
| Other Non-current Liabilities | 6.39M | 3.27M | 3.4M | 3.41M | 3.89M |
| Total Non-current Liabilities | 8.37M | 4.58M | 29.51M | 39.92M | 31.57M |
| Total Liabilities | 25.47M | 16.5M | 55.78M | 60.08M | 54.14M |
| Common Stock | 239K | 240K | 247K | 248K | 262K |
| Retained Earnings | (422.08M) | (455.77M) | (474.53M) | (488.76M) | (453.42M) |
| Accumulated OCI | 0 | 0 | 2K | 11K | 8K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 106.69M | 77.68M | 65.56M | 54.91M | 102.73M |
| Total Debt | 2.75M | 1.93M | 1.35M | 2.91M | 2.96M |
| Net Debt | (5.05M) | (9.13M) | (12.54M) | (15.32M) | (87.64M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $12.4M |
| Short-term Investments | $122.5M |
| Receivables | $2.3M |
| Total Current Assets | $137.3M |
| PP&E (Net) | $3.1M |
| Long-term Investments | $452.0K |
| Other Non-current | $5.0M |
| Total Non-current Assets | $8.6M |
| Total Assets | $145.9M |
Analysis
Selected assets total $145.9M for Latest. The largest visible component is Short-term Investments at $122.5M, about 84.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 9, 2026 | |
| 6-K | 6-K filing | Sep 10, 2026 | |
| 6-K | 6-K filing | Aug 3, 2026 | |
| 6-K | 6-K filing | Aug 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 30, 2026 |
How much cash does CGEN have?
Compugen Ltd. (CGEN) reported $90.60M in cash and equivalents in fiscal 2025.
How much debt does CGEN carry?
Compugen Ltd. (CGEN) reported $2.96M of total debt, with net debt of -$87.64M.
Continue the stock analysis
Jump to another research area for this company.